PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of iaiPermissionsJournals.ASM.orgJournalIAI ArticleJournal InfoAuthorsReviewers
 
Infect Immun. 1985 June; 48(3): 607–610.
PMCID: PMC261202

Lack of antibacterial activity after intravenous hydrogen peroxide infusion in experimental Escherichia coli sepsis.

Abstract

The intravenous administration of hydrogen peroxide has been reported to benefit patients with pneumonia and to reduce Plasmodium parasitemia in experimentally infected mice. We assessed the antibacterial activity of intravenously infused hydrogen peroxide against hydrogen peroxide-susceptible Escherichia coli (MBC of hydrogen peroxide, 0.23 mM) in experimentally infected rabbits. No decrease in the level of bacteremia was detected at the maximum intravenous infusion rate of hydrogen peroxide physiologically tolerated by the rabbits (2.0 mumol/h). Moreover, the addition ex vivo of greater amounts of hydrogen peroxide to human or murine blood containing E. coli resulted in no detectable antibacterial action. In contrast, ethyl hydrogen peroxide, which is not affected by catalase, was bactericidal when added ex vivo to human blood containing E. coli. These results suggest that extracellular hydrogen peroxide, whether of exogenous or endogenous origin, does not have antibacterial activity in the blood of animals having even low levels of catalase.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (806K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Babior BM. Oxygen-dependent microbial killing by phagocytes (second of two parts). N Engl J Med. 1978 Mar 30;298(13):721–725. [PubMed]
  • Baehner RL, Nathan DG, Karnovsky ML. Correction of metabolic deficiencies in the leukocytes of patients with chronic granulomatous disease. J Clin Invest. 1970 May;49(5):865–870. [PMC free article] [PubMed]
  • Butler BD, Hills BA. The lung as a filter for microbubbles. J Appl Physiol Respir Environ Exerc Physiol. 1979 Sep;47(3):537–543. [PubMed]
  • Cooperstock MS, Tucker RP, Baublis JV. Possible pathogenic role of endotoxin in Reye's syndrome. Lancet. 1975 Jun 7;1(7919):1272–1274. [PubMed]
  • Dockrell HM, Playfair JH. Killing of blood-stage murine malaria parasites by hydrogen peroxide. Infect Immun. 1983 Jan;39(1):456–459. [PMC free article] [PubMed]
  • Glode MP, Sutton A, Moxon ER, Robbins JB. Pathogenesis of neonatal Escherichia coli meningitis: induction of bacteremia and meningitis in infant rats fed E. coli K1. Infect Immun. 1977 Apr;16(1):75–80. [PMC free article] [PubMed]
  • Granoff DM, Rockwell R. Experimental Haemophilus influenzae type b meningitis: immunological investigation of the infant rat model. Infect Immun. 1978 Jun;20(3):705–713. [PMC free article] [PubMed]
  • Johnston RB, Jr, Baehner RL. Improvement of leukocyte bactericidal activity in chronic granulomatous disease. Blood. 1970 Mar;35(3):350–355. [PubMed]
  • LORINCZ AL, JACOBY JJ, LIVINGSTONE HM. Studies on the parenteral administration of hydrogen peroxide. Anesthesiology. 1948 Mar;9(2):162–174. [PubMed]
  • MALLAMS JT, FINNEY JW, BALLA GA. The use of hydrogen peroxide as a source of oxygen in a regional intra-arterial infusion system. South Med J. 1962 Mar;55:230–232. [PubMed]
  • Nathan C, Cohn Z. Role of oxygen-dependent mechanisms in antibody-induced lysis of tumor cells by activated macrophages. J Exp Med. 1980 Jul 1;152(1):198–208. [PMC free article] [PubMed]
  • Nathan CF, Brukner LH, Silverstein SC, Cohn ZA. Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide. J Exp Med. 1979 Jan 1;149(1):84–99. [PMC free article] [PubMed]
  • Nathan CF, Cohn ZA. Antitumor effects of hydrogen peroxide in vivo. J Exp Med. 1981 Nov 1;154(5):1539–1553. [PMC free article] [PubMed]
  • Nathan CF, Silverstein SC, Brukner LH, Cohn ZA. Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity. J Exp Med. 1979 Jan 1;149(1):100–113. [PMC free article] [PubMed]
  • Robbins JB, McCracken GH, Jr, Gotschlich EC, Orskov F, Orskov I, Hanson LA. Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis. N Engl J Med. 1974 May 30;290(22):1216–1220. [PubMed]
  • Rudbach JA, Akiya FI, Elin RJ, Hochstein HD, Luoma MK, Milner EC, Milner KC, Thomas KR. Preparation and properties of a national reference endotoxin. J Clin Microbiol. 1976 Jan;3(1):21–25. [PMC free article] [PubMed]
  • Shenep JL, Mogan KA. Kinetics of endotoxin release during antibiotic therapy for experimental gram-negative bacterial sepsis. J Infect Dis. 1984 Sep;150(3):380–388. [PubMed]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)